This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event September 20-22, 2021
In-Person: September 20-21 • Virtual: September 22Aloft Boston Seaport District • Boston, MA

Joseph Thome, PhD
Director, Senior Biotechnology Equity Research Analyst at Cowen and Company

Profile

Joseph Thome is a director and senior research analyst on Cowen and Company’s biotechnology team. Dr. Thome was selected as a “Rising Star in Equity Research” by Business Insider in 2021 and the Cowen biotechnology team has consistently been among the top-ranked teams in the Greenwich Survey.

Prior to joining Cowen in March 2016, Dr. Thome was an NIH pre-doctoral research fellow at Columbia University, studying the compartmentalization and maintenance of the human T cell immune response from infancy into adulthood. His research has been published in several prestigious journals including Cell and Nature Medicine.

Dr. Thome received a BA with high honors in chemistry and biochemistry from Oberlin College and a Ph.D. in microbiology and immunology from Columbia University, where he was granted the Dean’s Award for Excellence in Research.

Joseph Thome, PhD's Network

Agenda Sessions

  • Biotech Equity Funding Models and Pathways — Venture Capital and the Public Markets

    1:30pm